Incidence of adverse drug reactions induced by N-acetylcysteine in patients with acetaminophen overdose

Abstract

Background: Intravenous N-acetylcysteine (IV-NAC) is widely recognized as the antidote of choice for acetaminophen overdose. However, its use is not without adverse drug reactions (ADR) that might affect therapeutic outcome or lead to treatment delay. Objective: the aim of this study was to investigate the type and incidence of ADR induced by IV-NAC in patients treated for acetaminophen overdose. Methods: This is a retrospective study of patients admitted to the hospital for acute acetaminophen overdose over a period of 4 years (1 January 2005 to 31 December 2008). The primary outcome of interest in this study was the occurrence of ADR during NAC administration. Pearson chi-square test or Fisher’s exact test, student’s t test, and Mann-Whitney U test were used in univariate analysis. SPSS 15 was used for data analysis. Results: Two hundred and fifty five patients were studied. Different types of ADR were observed in 119 (46.7%) cases. Of those patients, 83 (69.7%) had been treated with IV-NAC versus 36 (30.3%) who had not (p < .001). The following ADR were significantly associated with IV-NAC administration: vomiting (p = .001), flushing (p < .001), rash (p < .001), pruritus (p < .001), chest pain (p = .001), bronchospasm (p = .03), coughing (p = .01), headache (p = .001), dizziness (p < .001), convulsion (p = .03), and hypotension (p = .001). ADR were mild in 54 (43.2%), moderate in 17 (13.6%), and severe in 12 (9.6%) patients. There were no ADR in 42 (33.6%) patients. Comparative results of the characteristics of patients who reacted to IV-NAC and nonreactors showed that patients with ADR had no significant difference in age, gender, ethnicity, amount ingested, latency time, and acetaminophen level than nonreactors. Conclusion: ADR to IV-NAC were common among patients with acetaminophen overdose, but mostly minor and all reported adverse reactions were easily managed.

Keywords

acetaminophen adverse drug reaction N-acetylcysteine overdose

References

Larson AM Acetaminophen hepatotoxicity. Clin Liver Dis 2007; 11: 525-548.

Larson AM , Polson J. , Fontana RJ , et al., Acute Liver Failure Study Group. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42: 1364-1372.

Ayonrinde OT , Phelps GJ , Hurley JC , Ayonrinde OA Paracetamol overdose and hepatotoxicity at a regional Australian hospital: a 4-year experience. Intern Med J 2005; 35: 655-660.

Thanacoody HK , Good AM , Waring WS , Bateman DN Survey of cases of paracetamol overdose in the UK referred to National Poisons Information Service (NPIS) consultants . Emerg Med J 2008; 25: 140-143.

Lall SB , Al-Wahaibi SS , Al-Riyami MM , Al-Kharusi K. Profile of acute poisoning cases presenting to health centres and hospitals in Oman. East Mediterr Health J 2003; 9: 944-954.

Rajasuriar R. , Awang R. , Hashim SB , Rahmat HR Profile of poisoning admissions in Malaysia . Hum Exp Toxicol 2007; 26: 73-81.

Daly FF , Fountain JS , Murray L. , Graudins A. , Buckley NA ; Panel of Australian and New Zealand clinical toxicologists. Guidelines for the management of paracetamol poisoning in Australia and New Zealand - explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. Med J Aust 2008; 188: 296-301.

Tan HH , Chang CY , Martin P. Acetaminophen hepatotoxicity: current management. Mt Sinai J Med 2009; 76: 75-83.

Sandilands EA , Bateman DN Adverse reactions associated with acetylcysteine . Clin Toxicol (Phila) 2009; 47: 81-88.

10.

Mohammed S. , Jamal AZ , Robison LR Serum sickness-like illness associated with N-acetylcysteine therapy. Ann Pharmacother 1994; 28: 285.

11.

Hershkovitz E. , Shorer Z. , Levitas A. , Tal A. Status epilepticus following intravenous N-acetylcysteine therapy. Isr J Med Sci 1996; 32: 1102-1104.

12.

Bailey B. , Blais R. , Letarte A. Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death. Ann Emerg Med 2004; 44: 401-406.

13.

Bonfiglio MF , Traeger SM , Hulisz DT , Martin BR Anaphylactoid reaction to intravenous acetylcysteine associated with electrocardiographic abnormalities. Ann Pharmacother 1992; 26: 22-25.

14.

Walton NG , Mann TA , Shaw KM Anaphylactoid reaction to N-acetylcysteine. Lancet 1979; 2: 1298.

15.

Bateman DN , Woodhouse KW , Rawlins MD Adverse reactions to N-acetylcysteine. Hum Toxicol 1984; 3: 393-398.

16.

Mant TG , Tempowski JH , Volans GN , Talbot JC Adverse reactions to acetylcysteine and effects of overdose. BMJ (Clin Res Ed) 1984; 289: 217-219.

17.

Dawson AH , Henry DA , McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning . Med J Aust 1989; 150: 329-331.

18.

Suenobu T. , Yoshioka T. , Maruta S. , Shimoji H. Post-marketing surveillance of acetylcysteine oral solution 17.6% ‘‘SENJU’’ for the antidote to acetaminophen overdose - use - results surveillance. Chudoku Kenkyu 2006; 19: 383-394.

19.

Schmidt LE , Dalhoff K. Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning. Br J Clin Pharmacol 2001; 51: 87-91.

20.

Kao LW , Kirk MA , Furbee RB , Mehta NH , Skinner JR , Brizendine EJ

What is the rate of adverse events after oral N-acetylcysteine administered by the intravenous route to patients with suspected acetaminophen poisoning?

Ann Emerg Med 2003; 42: 741-750.

21.

Lynch RM , Robertson R. Anaphylactoid reactions to intravenous N-acetylcysteine: a prospective case controlled study. Accid Emerg Nurs 2004; 12: 10-15.

22.

Gheshlagi F. , Izadi-Mood N. , Amini R. , Montazeri G. Prevalence of hypersensitivity reactions to intravenous N-acetylcysteine in acetaminophen poisoned patients. Clin Toxicol 2005; 43: 514-515.

23.

Merl W. , Koutsogiannis Z. , Kerr D. , Kelly AM

How safe is intravenous N-acetylcysteine for the treatment of paracetamol poisoning?

Hong Kong J Emerg Med 2007; 14: 198-203.

24.

Whyte IM , Francis B. , Dawson AH Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin 2007; 23: 2359-2368.

25.

Waring WS , Stephen AF , Robinson OD , Dow MA , Pettie JM Lower incidence of anaphylactoid reactions to N-acetylcysteine in patients with high acetaminophen concentrations after overdose. Clin Toxicol 2008; 46: 496-500.

26.

Pakravan N. , Waring WS , Sharma S. , Ludlam C. , Megson I. , Bateman DN Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose. Clin Toxicol 2008; 46: 697-702.

27.

Bailey B. , McGuigan MA Management of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998; 31: 710-715.

28.

Rumack BH , Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55: 871-876.